Can NK cells be a therapeutic target in human type 1 diabetes?
Authors:
- 7 November 2008
- journal article
- review article
- Published by Wiley in European Journal of Immunology
- Vol. 38 (11) , 2961-2963
Abstract
Type 1 diabetes is caused by the autoimmune destruction of insulin‐producing cells with consequent hyperglycemia and serious chronic complications. Both innate and adaptive immune responses participate in disease pathogenesis. Studies in animal models and in man have shown that NK cells are involved both in disease progression and in disease protection, thus suggesting that NK cells can represent a potential therapeutic target in type 1 diabetes, once the contribution of these cells to islet autoimmunity has been fully elucidated.Keywords
This publication has 23 references indexed in Scilit:
- Critical role for IFN‐γ in natural killer cell‐mediated protection from diabetesEuropean Journal of Immunology, 2007
- Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patientsProceedings of the National Academy of Sciences, 2007
- Altered Natural Killer Cells in Type 1 Diabetic PatientsDiabetes, 2007
- NK cells promote islet allograft tolerance via a perforin-dependent mechanismNature Medicine, 2005
- Impairment of NK Cell Function by NKG2D Modulation in NOD MiceImmunity, 2003
- Target cell defense prevents the development of diabetes after viral infectionNature Immunology, 2002
- Cytotoxic activity in children with insulin-dependent diabetes mellitusDiabetes Research and Clinical Practice, 1994
- Immune Responses to Insulin and Lymphocyte Subclasses at Diagnosis of Insulin-Dependent Diabetes and One Year LaterImmunobiology, 1990
- Immunoregulatory dysfunctions in type I diabetes: Natural and antibody-dependent cellular cytotoxic activitiesJournal of Clinical Immunology, 1986
- Natural killer cells in insulin dependent diabetes mellitus.BMJ, 1986